FDA Updates Information on Automated Endoscope Reprocessors
Earlier this month, the Food and Drug Administration (FDA) updated its webpage, “Information About Automated Endoscope Reprocessors (AERs) and FDA’s Evaluation” to communicate that Medivators’ CER Optima AER shows adequate validation test results for open and closed channel duodenoscopes. The FDA is looking into all critical factors contributing to patient infections associated with exposure to duodenoscopes and how best to mitigate them, including how AERs are used in clinical settings. The FDA continues to update the “AER Validation Testing Status” section of the webpage as it accepts validation test results from AER manufacturers.
Strengthening Defenses: Integrating Infection Control With Antimicrobial Stewardship
October 11th 2024Use this handout to explain the basics of why infection prevention and control and antimicrobial stewardship are essential and how the 2 fields must have a unified approach to patient and staff safety
Barrier Against Infection: Importance and Challenges of Isolation Room Cleaning in Hospitals
October 4th 2024Isolation rooms are essential for infection control in health care, relying on specialized design, advanced cleaning protocols, and technology to prevent cross-contamination and safeguard patient safety.
